Document is current
Any future updates will be listed below
-
Authors
Powell, Abigail E. https://orcid.org/0000-0001-6408-9495
Caruso, Hannah https://orcid.org/0009-0001-9625-9986
Park, Soyoon https://orcid.org/0000-0002-7399-411X
Chen, Jui-Lin
O’Rear, Jessica
Ferrer, Brian J. https://orcid.org/0000-0003-0500-146X
Stieh, Daniel J. https://orcid.org/0009-0003-8523-1528
Weiss, Adam M. https://orcid.org/0000-0002-4972-1402
Belnap, David M. https://orcid.org/0000-0002-0619-7487
Walker, Audrey
Bruening, Anneliese
Hartwig, Airn
Sprouse, Kaitlin R. https://orcid.org/0000-0003-0007-2226
Addetia, Amin
Alshukairi, Abeer N.
Ahyong, Vida
Dougherty, Cristy S.
Veesler, David https://orcid.org/0000-0002-6019-8675
Bowen, Richard https://orcid.org/0000-0002-7576-2881
Ledgerwood, Julie E.
Kay, Michael S. https://orcid.org/0000-0003-3186-9684
Weidenbacher, Payton A.-B.
Palanski, Brad A.
-
Funding
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (P01AI167966)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DP1AI158186)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (75N93022C00036)
Burroughs Wellcome Fund
- License Information
-
More Information
Article History
Received: 21 February 2025
Accepted: 7 January 2026
First Online: 5 February 2026
Competing interests
: A.E.P., S.P., J.O., J.E.L., P.A.W., and B.A.P. are listed as inventors on US patent application 63/587,130, entitled “Engineered Middle East Respiratory Syndrome Proteins and Related Methods” which discloses subject matter described in this paper. A.E.P., H.C., J.L.C., J.O., B.J.F., D.J.S., A.M.W., J.E.L., P.A.W., and B.A.P. are employees of and may hold shares in Vaccine Company, Inc. S.P., V.A., C.S.D., and M.S.K. are former employees of Vaccine Company, Inc. The remaining authors declare no competing interests.
